StrokeDx
Yorba Linda, US · Founded 2022
Founders & leadership
AB
Alexander BallatoriChief Executive Officer
SS
Reported raises · per SEC filings
Form D private placements$6M disclosed across 2 rounds · 2022–2024
▶$4.3MraisedJun 2024 · 3 investors · Other Health CareRule 506(b)
▶$4.3MraisedJun 2024 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Kevin BarrettDirector
- Alexander BallatoriExecutive Officer, Director
- Shane ShahrestaniExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $4.3M
- First sale
- May 2024
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$1.7MraisedOct 2022 · 5 investors · Other Health CareRule 506(b)
▶$1.7MraisedOct 2022 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Alexander BallatoriExecutive Officer, Director
- Shane ShahrestaniExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $1.7M
- First sale
- Oct 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has StrokeDx raised?
- StrokeDx has disclosed $6M raised across 2 rounds.
- Where is StrokeDx headquartered?
- StrokeDx is headquartered in Yorba Linda, US.